You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Link Details
- Metabolite
- HMDB0000234 (Testosterone)
- DrugBank ID
- DB06719
- Drug Name
- Buserelin
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Kirby RS, Fitzpatrick JM, Clarke N: Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer. BJU Int. 2009 Dec;104(11):1580-4. doi: 10.1111/j.1464-410X.2009.08924.x. [PubMed:20053189 ]
- Fruzzetti F, Melis GB, Mais V, Beconcini D, Paoletti AM, Cristiani G, Mian E, Fioretti P: High testosterone levels of ovarian origin affect adrenal steroidogenesis? J Clin Endocrinol Metab. 1991 Feb;72(2):426-31. [PubMed:1846875 ]
- Lemay A, Faure N, Labrie F: Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women. Fertil Steril. 1982 Feb;37(2):193-200. [PubMed:6800846 ]
- Urbancsek J, Rabe T, Gor U, Schulte B, Grunwald K, Papp Z, Runnebaum B: [Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration]. Geburtshilfe Frauenheilkd. 1991 Aug;51(8):617-25. [PubMed:1834511 ]
- Faure N, Labrie F, Lemay A, Belanger A, Gourdeau Y, Laroche B, Robert G: Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertil Steril. 1982 Mar;37(3):416-24. [PubMed:6800852 ]
- Ferrari V, Zaniboni A, Simoncini E, Marpicati E, Montini E, Moretti R, Marini G: Complete estrogen blockade with buserelin and aminoglutethimide for advanced breast cancer: a phase I-II study with long-term hormonal correlations. Chemioterapia. 1988 Dec;7(6):414-9. [PubMed:3146444 ]
- Tayek JA, Heber D, Byerley LO, Steiner B, Rajfer J, Swerdloff RS: Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism. 1990 Dec;39(12):1314-9. [PubMed:2123281 ]